E. Sánchez-Ferrero

发表

Spinocerebellar ataxia type 15: diagnostic assessment, frequency, and phenotypic features

T. Nägele, P. Bauer, L. Schöls, 2011, Journal of Medical Genetics.

Mitochondrial transcription factor A (TFAM) gene variation and risk of late-onset Alzheimer's disease.

V. Álvarez, E. Coto, M. García-Castro, 2008, Journal of Alzheimer's disease : JAD.

SPG7 mutational screening in spastic paraplegia patients supports a dominant effect for some mutations and a pathogenic role for p.A510V

V. Álvarez, E. Coto, J. Infante, 2013, Clinical genetics.

Mutational screening of the mortalin gene (HSPA9) in Parkinson’s disease

V. Álvarez, E. Coto, M. Blázquez, 2009, Journal of Neural Transmission.

Mutational screening of the mitochondrial transcription factors B1 and B2 (TFB1M and TFB2M) in Parkinson's disease.

V. Álvarez, E. Coto, M. Blázquez, 2009, Parkinsonism & related disorders.

Mitochondrial transcription factor A (TFAM) gene variation in Parkinson's disease

V. Álvarez, E. Coto, M. Blázquez, 2008, Neuroscience Letters.

Mutational spectrum of the SPG4 (SPAST) and SPG3A (ATL1) genes in Spanish patients with hereditary spastic paraplegia

V. Álvarez, E. Coto, J. Rosell, 2010, BMC neurology.

Mutational spectrum of the SPG 4 ( SPAST ) and SPG 3 A ( ATL 1 ) genes in Spanish patients with hereditary spastic paraplegia

V. Álvarez, E. Coto, J. Rosell, 2010 .

Mitochondrial DNA polymorphisms/haplogroups in hereditary spastic paraplegia

V. Álvarez, E. Coto, J. Infante, 2012, Journal of Neurology.

MLPA-based evidence for sequence gain: pitfalls in confirmation and necessity for exclusion of false positives.

C. Beetz, Rita-Eva Varga, Rizwan Mumtaz, 2012, Analytical biochemistry.

No association between Parkinson's disease and three polymorphisms in the eNOS, nNOS, and iNOS genes

V. Álvarez, E. Coto, M. Blázquez, 2007, Neuroscience Letters.